Clumps or plaques of the protein beta-amyloid in the brain are a hallmark of a type of dementia called Alzheimer’s disease. When beta-amyloid plaques form, they disrupt communication between nerve ...

Microglia (green) responding to aggregated beta-amyloid plaques (blue) in the mouse cortex. (Credit: Jessica M. Crowley) A ...

An international team of scientists has developed specialized nanoparticles that can reverse the cognitive symptoms of Alzheimer’s disease in mice. The treatment works by repairing the brain’s natural ...

Have you ever caught yourself absentmindedly picking your nose in a quiet moment? It feels like a private, harmless habit ...

Specially engineered 'young' immune cells could help to reverse the effects of aging and the damage to brain cells caused by ...

Researchers have uncovered how the brain’s immune cells, called microglia, can act as protectors rather than destroyers in Alzheimer’s disease.

Amyloid beta is a peptide that plays a central role in the neurodegenerative pathology of Alzheimer’s disease by aggregating into plaques in the brain. U.S. Food and Drug Administration (FDA) approved ...

The buildup of amyloid beta plaques in the brain has long been associated with the development of Alzheimer’s disease, making them a frequent target for novel treatments of the neurodegenerative ...

P-tau217 and p-tau181 are some of the earliest known markers of Alzheimer’s disease, rising in blood and cerebrospinal fluid 20 years before symptoms appear. But what do these markers mean? In the ...